Thalassemia Clinical Trials in Athens
5 recruitingAthens, Greece
Showing 1–5 of 5 trials
Recruiting
Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Beta-Thalassemia
Celgene99 enrolled26 locationsNCT04143724
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Phase 4
CINC424A2X01B Rollover Protocol
Acute Myeloid LeukemiaPolycythemia VeraGraft-Versus-Host Disease+2 more
Novartis Pharmaceuticals296 enrolled101 locationsNCT02386800
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled105 locationsNCT06609226
Recruiting
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Sickle Cell DiseaseHemoglobinopathiesThalassemia Alpha+1 more
Cyprus Institute of Neurology and Genetics30,000 enrolled26 locationsNCT05799118